PT89837A - Processo para a preparacao de composicoes para aumentar o fluxo transdermico contendo uma 1-alquilazaciclo-heptan-2-ona ou uma cis-olefina - Google Patents

Processo para a preparacao de composicoes para aumentar o fluxo transdermico contendo uma 1-alquilazaciclo-heptan-2-ona ou uma cis-olefina

Info

Publication number
PT89837A
PT89837A PT89837A PT8983789A PT89837A PT 89837 A PT89837 A PT 89837A PT 89837 A PT89837 A PT 89837A PT 8983789 A PT8983789 A PT 8983789A PT 89837 A PT89837 A PT 89837A
Authority
PT
Portugal
Prior art keywords
cis
olefin
alkylazacyclo
ona
heptan
Prior art date
Application number
PT89837A
Other languages
English (en)
Other versions
PT89837B (pt
Inventor
Michael Lee Francoeur
Russell Owen Potts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT89837A publication Critical patent/PT89837A/pt
Publication of PT89837B publication Critical patent/PT89837B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT89837A 1988-02-29 1989-02-24 Processo para a preparacao de composicoes para aumentar o fluxo transdermico contendo uma 1-alquilazaciclo-heptan-2-ona ou uma cis-olefina PT89837B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16192688A 1988-02-29 1988-02-29

Publications (2)

Publication Number Publication Date
PT89837A true PT89837A (pt) 1989-10-04
PT89837B PT89837B (pt) 1994-01-31

Family

ID=22583397

Family Applications (1)

Application Number Title Priority Date Filing Date
PT89837A PT89837B (pt) 1988-02-29 1989-02-24 Processo para a preparacao de composicoes para aumentar o fluxo transdermico contendo uma 1-alquilazaciclo-heptan-2-ona ou uma cis-olefina

Country Status (11)

Country Link
EP (1) EP0331382B1 (pt)
JP (1) JPH0768147B2 (pt)
AT (1) ATE80313T1 (pt)
CA (1) CA1331137C (pt)
DE (1) DE68902753T2 (pt)
DK (1) DK93289A (pt)
ES (1) ES2051998T3 (pt)
FI (1) FI92650C (pt)
GR (1) GR3005657T3 (pt)
IE (1) IE61946B1 (pt)
PT (1) PT89837B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0425443A1 (de) * 1989-10-27 1991-05-02 Ciba-Geigy Ag Injizierbares parasitizides Mittel
US5023085A (en) * 1989-11-29 1991-06-11 Pfizer Inc. Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
ATE95421T1 (de) * 1990-04-26 1993-10-15 Sagitta Arzneimittel Gmbh Piroxicam enthaltende pharmazeutische zusammensetzung zur topischen anwendung.
WO1992017185A1 (en) * 1991-03-29 1992-10-15 University Of Florida Targeted drug delivery via mixed phosphate derivatives
EP0612526A4 (en) * 1991-11-15 1995-08-02 Ss Pharmaceutical Co ANTI-INFLAMMATORY AND ANALGESIC PLATTER.
EP0676962B9 (en) * 1992-12-31 2002-04-03 Sunkyong Industries Co., Ltd. Enhanced pharmaceutical compositions for skin penetration for piroxicam
DE4341572C1 (de) * 1993-12-07 1995-06-22 Univ Dresden Tech Zahnriemengetriebe
GB9404248D0 (en) * 1994-03-05 1994-04-20 Boots Co Plc Pharmaceutical formulations
US6106856A (en) * 1994-03-09 2000-08-22 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Transdermal delivery of calcium channel blockers, such as nifedipine
UA48212C2 (uk) 1996-01-31 2002-08-15 Сергей Дмітрієвіч БУРЛАКОВ Антиглюкокортикоїдний лікарський засіб
CA2285368A1 (en) * 1997-03-31 1998-10-08 Johnson & Johnson Consumer Companies Inc. Solvent system for enhanced penetration of pharmaceutical compounds
DK1510213T3 (da) 1997-11-10 2009-03-23 Strakan Int Ltd Penetrationsforbedrende og irritationsreducerende systemer omfattende testosteron
JP4626202B2 (ja) * 2003-07-16 2011-02-02 大正製薬株式会社 ピロキシカム含有外用消炎鎮痛剤組成物
JP2006188500A (ja) * 2004-12-08 2006-07-20 Toyama Chem Co Ltd ピロキシカムを含有する外用液剤
AU2009264307A1 (en) * 2008-06-24 2009-12-30 Intervet International B.V. Pharmaceutical transdermal compositions and method for treating inflammation in cattle
GB0906868D0 (en) * 2009-04-21 2009-06-03 Rabin Bennie Amlodipine salt compositions
AU2019276832B2 (en) * 2018-06-01 2024-08-15 Tavanta Therapeutics Hungary Incorporated Topical amlodipine salts for the treatment of anorectal diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2314731A1 (fr) * 1975-06-19 1977-01-14 Nelson Res & Dev Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
JPS60199834A (ja) * 1984-03-23 1985-10-09 Takeda Chem Ind Ltd 経皮吸収外用製剤
JPS59216818A (ja) * 1983-05-26 1984-12-06 Takeda Chem Ind Ltd 経皮吸収外用製剤
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
MY102980A (en) * 1986-10-31 1993-03-31 Pfizer Transdermal flux enhancing compositions

Also Published As

Publication number Publication date
ATE80313T1 (de) 1992-09-15
DE68902753T2 (de) 1993-01-21
PT89837B (pt) 1994-01-31
DE68902753D1 (de) 1992-10-15
EP0331382A2 (en) 1989-09-06
EP0331382A3 (en) 1990-05-30
FI890930A0 (fi) 1989-02-27
JPH023613A (ja) 1990-01-09
JPH0768147B2 (ja) 1995-07-26
ES2051998T3 (es) 1994-07-01
DK93289A (da) 1989-08-30
GR3005657T3 (pt) 1993-06-07
DK93289D0 (da) 1989-02-27
FI890930A (fi) 1989-08-30
FI92650C (fi) 1994-12-27
CA1331137C (en) 1994-08-02
IE61946B1 (en) 1994-11-30
FI92650B (fi) 1994-09-15
EP0331382B1 (en) 1992-09-09
IE890642L (en) 1989-08-29

Similar Documents

Publication Publication Date Title
EG18324A (en) Transdermal flux enhancing compositions
PT89837A (pt) Processo para a preparacao de composicoes para aumentar o fluxo transdermico contendo uma 1-alquilazaciclo-heptan-2-ona ou uma cis-olefina
IS1262B6 (is) Ný samsetning efnis
AR241752A1 (es) Composicion adhesiva para mejorar la adhesion entre la dentina y rellenos dentales y procedimiento para su preparacion.
ATE15749T1 (de) Synergistische konservierungszusammensetzungen, diese enthaltende produkte und verfahren zu ihren gebrauch.
ATE41772T1 (de) Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
FR2410641A1 (fr) Formes racemiques et optiquement actives de (biphenylyl-4)-2 n-(diethylamino alkyl) propionamides et de leurs sels utiles comme agents spasmolytiques et procedes de preparation
ATE214269T1 (de) Oral anzuwendende flüssige arzneilösung
RU2002113657A (ru) Пролекарства 6-метокси-2-нафтилуксусной кислоты
ATE41774T1 (de) (+)-cyanidan-3-ol derivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische praeparate und deren verwendung.
KR830006178A (ko) 부작용감소와 약효시간이 연장된 새로운 기관지 진정제의 제조방법
KR920011486A (ko) 항종양제
RU95106650A (ru) Фармацевтические композиции для предотвращения образования метастазов рака в печени и фармацевтическая композиция для лечения рака печени, способ лечения, способ получения композиции, применение цитарабин окфосфата для получения фармацевтической композиции
JPH04128220A (ja) 抗ヘルペスウイルス剤

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19930719

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19990131